好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Refractory status epilepticus as a predictor of tumor progression and poor prognostic indicator
Neuro-oncology
P6 - (-)
144
Authors/Disclosures
Dana L. Vanino, DO (Geisinger Medical Center)
PRESENTER
Dr. Vanino has nothing to disclose.
Cynthia Correll, MD (Cayuga Medical Associates) Dr. Correll has nothing to disclose.
Na Tosha N. Gatson, MD, PhD, FAAN Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.